ICLR: ICON Public Limited Company - Summary | Jitta

ICON Public Limited Company

NASDAQ:ICLR

Price
$216.18
Loss Chance
43.1%
6.14JITTA SCORE
79.32%Over Jitta Line
Jitta Ranking
102 / 1,009
1,433 / 4,503
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (39)
Recent Business Performance (51)
Financial Strength (92)
Return to Shareholders (61)
Competitive Advantage (68)
Jitta Signs
Revenue and EarningConsistent
Debt LevelLow Long Term Debt
Return on EquityConsistently High
CapExVery Low
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Recent Business PerformanceEarning decline 6.58% in the last year
Key Stats
Jitta Score
Jitta Line
6.14
79.32%
2.29
> 1,000%
Life Sciences Tools and Services
7.15
142.86%
5.51
0.13%
6.99
115.69%
COMPANY DESCRIPTION
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. The company’s clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional solutions, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.